India’s cheap weight-loss drugs could reshape global obesity fight

Voicefm Ghana March 19, 2026 1 minute read

India’s semaglutide patent expiry is set to trigger a wave of cheaper generic weight-loss drugs, potentially cutting prices by over 50% and transforming treatment for millions with diabetes and obesity.

Voicefm Ghana

Editor

Visit Website View All Posts

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

Related Stories

Vivo Energy Ghana hosts ShePower Summit 2026 to inspire next generation of Women in STEM

Upper West Eid prayers: Leaders unite against youth drug abuse, call for educational reforms

CNMRU partners Police to enforce road safety among okada riders in Kpone Katamanso

You may have missed

Vivo Energy Ghana hosts ShePower Summit 2026 to inspire next generation of Women in STEM

Upper West Eid prayers: Leaders unite against youth drug abuse, call for educational reforms

CNMRU partners Police to enforce road safety among okada riders in Kpone Katamanso

Is McDan’s case with GACL a test of Ghana’s commitment to investors?

About the Author

Related Stories

You may have missed